POULTON STUART (EVP, Chief Development Officer) received a stock award from KARYOPHARM THERAPEUTICS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 10/16/2025ACC: 0001193125-25-241484
Officer· EVP, Chief Development Officer
Since Mar 2026
+39.68K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
39.68K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+39.68K
Price / share
—
Trade value
—
% of position
143.2%
10/15/2025
27.71K→67.39K
Total
Net shares
+39.68K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/15/2025 | A · Award | +39.68K | — | — | 143.2% | 27.71K | 67.39K |
| Total | +39.68K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported